JPMORGAN CHASE & CO - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$3,000
-93.5%
2,232
-95.5%
0.00%
Q1 2020$46,000
+70.4%
49,492
+190.8%
0.00%
Q4 2019$27,000
-87.4%
17,021
-72.2%
0.00%
Q3 2019$215,000
+119.4%
61,318
+144.6%
0.00%
Q2 2019$98,000
-49.5%
25,064
+35.5%
0.00%
Q1 2019$194,000
+32.9%
18,499
+31.6%
0.00%
Q4 2018$146,000
-4.6%
14,054
+10.6%
0.00%
Q3 2018$153,000
+466.7%
12,712
+464.0%
0.00%
Q2 2018$27,0002,2540.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders